<code id='CE24CF0BE1'></code><style id='CE24CF0BE1'></style>
    • <acronym id='CE24CF0BE1'></acronym>
      <center id='CE24CF0BE1'><center id='CE24CF0BE1'><tfoot id='CE24CF0BE1'></tfoot></center><abbr id='CE24CF0BE1'><dir id='CE24CF0BE1'><tfoot id='CE24CF0BE1'></tfoot><noframes id='CE24CF0BE1'>

    • <optgroup id='CE24CF0BE1'><strike id='CE24CF0BE1'><sup id='CE24CF0BE1'></sup></strike><code id='CE24CF0BE1'></code></optgroup>
        1. <b id='CE24CF0BE1'><label id='CE24CF0BE1'><select id='CE24CF0BE1'><dt id='CE24CF0BE1'><span id='CE24CF0BE1'></span></dt></select></label></b><u id='CE24CF0BE1'></u>
          <i id='CE24CF0BE1'><strike id='CE24CF0BE1'><tt id='CE24CF0BE1'><pre id='CE24CF0BE1'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:knowledge    Page View:983
          Adobe

          You’re reading the web version of Health Care Inc., STAT’s weekly newsletterfollowing the flow of money in medicine. Sign upto get it in your inbox every Monday.

          Always watch the courts

          There’s a joke that all reporters essentially are legal reporters. But it’s kind of true, especially within the health care beat.

          advertisement

          Congress can’t get anything done, and the federal agencies have their routine rule-making powers. But new, powerful business and health policy decisions get made in the courts — where companies, lobbying groups, and coalitions of people take the time and money to hire attorneys and fight for something that, ultimately, will benefit them financially.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Acelyrin, a rare IPO success, stumbles in its first big test
          Acelyrin, a rare IPO success, stumbles in its first big test

          MarkLennihan/APThebiotechcompanyAcelyrin,whichraisedmorethan$500millioninanIPOthisyear,ranintoitsfir

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          New weight loss drugs vying to be the next Wegovy or Mounjaro

          MollyFergusonforSTATTheexplodingpopularityofdrugslikeWegovyandMounjarohaspropelleddozensofcompaniest